Chronic idiopathic constipation (CIC) is a clinical condition comprised of a myriad of etiologies and subgroup that affects between fourteen and 28 percent of the U.S. population. Not only is it prevalent, but it is also expensive; it results in anywhere between two and a half and seven million healthcare visits each year at a cost of $29 billion. In spite of its widespread impact, it is thought to be underreported due to social perceptions and lack of a clear-cut definition for constipation. Symptoms may arise: as a result of poor nutrition, sedentary lifestyle, demographic predisposition; secondary to an adverse drug effect; from neuropsychiatric conditions; or completely idiopathically.
Agenda
The following healthcare professionals: gastroenterologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in gastroenterology; and any other healthcare professionals with an interest in or who clinically encounter patients with chronic idiopathic constipation.
This program is supported by an educational grant from Synergy Pharmaceuticals
Release Date: October 02, 2017 -- Expiration Date: October 02, 2019
Faculty: Joseph Weiss, MD
By the end of the session the participant will be able to:
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Joseph Weiss, MD, FACP, FACG, AGAF, Clinical Professor of Medicine University of California, San Diego has no relevant conflicts of interest to disclose.
Disclosures of Educational Planners: Charles Turck, PharmD, BCPS, BCCCP has no relevant conflicts of interest to disclose.
Commercial Support Disclosure: This program is supported by an educational grant from Synergy Pharmaceuticals
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.